Developing new medicines is a long, resource-intensive process, full of uncertainties. Our research into digital twinning allows us to simulate drug trials on virtual patients, accelerating early assessments of safety and efficacy with greater precision, and potentially reducing the need for large-scale clinical trials. This innovative approach is transforming our R&D landscape. #DigitalTwinning
Love this
In this edition of the New Medicines, Novel Insights newsletter, Paul Bridges chats with clinical experts from Parexel and Health Advances about the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Learn how these experts are helping biotech companies reduce risk by advocating for better coordination among departments, with a clear patient focus, at the earliest stages. Create success by planning for it ✅ Read the full article below and subscribe for our latest #NovelInsights #ParexelBiotech #ClinicalDevelopment #EarlyPhase #DrugDevelopment
Consultative Development Manager Parexel Biotech at Parexel #neverstopbioteching #clinicaltrials #patientsfirst #globalexpertise
In this edition of the New Medicines, Novel Insights newsletter, Paul Bridges chats with clinical experts from Parexel and Health Advances about the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Learn how these experts are helping biotech companies reduce risk by advocating for better coordination among departments, with a clear patient focus, at the earliest stages. Create success by planning for it ✅ Read the full article below and subscribe for our latest #NovelInsights #ParexelBiotech #ClinicalDevelopment #EarlyPhase #DrugDevelopment
In this edition of the New Medicines, Novel Insights newsletter, Paul Bridges chats with clinical experts from Parexel and Health Advances about the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Learn how these experts are helping biotech companies reduce risk by advocating for better coordination among departments, with a clear patient focus, at the earliest stages. Create success by planning for it ✅ Read the full article below and subscribe for our latest #NovelInsights #ParexelBiotech #ClinicalDevelopment #EarlyPhase #DrugDevelopment
In this edition of the New Medicines, Novel Insights newsletter, Paul Bridges chats with clinical experts from Parexel and Health Advances about the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Learn how these experts are helping biotech companies reduce risk by advocating for better coordination among departments, with a clear patient focus, at the earliest stages. Create success by planning for it ✅ Read the full article below and subscribe for our latest #NovelInsights #ParexelBiotech #ClinicalDevelopment #EarlyPhase #DrugDevelopment
Launching your iPS cell-based therapy? Lindville Bio (www.lindvillebio.com) is here to help. From lab to clinic, the journey of developing cell-based therapies is challenging, but with Lindville Bio by your side, we make it possible. We provide expert advice for: 1️⃣ iPS cell sourcing and quality control 2️⃣ iPS cell expansion and scale-up 3️⃣ Preclinical efficacy and safety testing 4️⃣ Navigating complex regulatory pathways 5️⃣ Manufacturing and process development 6️⃣ Designing and executing clinical trials 7️⃣ Intellectual property and competitive analysis 8️⃣ Ensuring reproducibility and consistency 9️⃣ Long-term safety monitoring 🔟 Securing funding and investment 1️⃣1️⃣ Tackling regulatory and legal hurdles 1️⃣2️⃣ Market access and commercialization Let's bring your therapy to life together. Arrange an initial discussion today at www.lindvillebio.com #iPSC #CellTherapy #Biotech #LindvilleBio #BiopharmaSolutions #HealthcareInnovation
Implementing efficient #randomisation adaptations in master protocols is one of Almac’s many solutions for increasing flexibility and efficiency in your clinical trial. What to know more about Almac's randomisation capabilities? Check out this latest whitepaper! https://okt.to/Qgi8Jn #clinicaltrials #drugdevelopment #clinicalresearch #biostats #biotech
In this edition of the New Medicines, Novel Insights newsletter, Paul Bridges chats with clinical experts from Parexel and Health Advances about the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Learn how these experts are helping biotech companies reduce risk by advocating for better coordination among departments, with a clear patient focus, at the earliest stages. Create success by planning for it ✅ Read the full article below and subscribe for our latest #NovelInsights #ParexelBiotech #ClinicalDevelopment #EarlyPhase #DrugDevelopment
🚨 Only 1 day to go until our webinar on the latest advancements in ADCs! Novel drug conjugates are emerging as a transformative force in the ADC space so don't miss this chance to dive deep into emerging trends and cutting-edge insights with our expert speakers, Yu-Shin Hsu and Callum Angus. ⏳ Last chance to register: 🔗 https://ter.li/rzae33 Whether you're in drug development or clinical research, this is the event to stay ahead! #ADCs #noveldrugconjugates #ADCinnovation #ADCclinicalsuccess #emergingADCs Hanson Wade Intelligence
Our comprehensive approach encompasses meticulous planning, efficient implementation, and precise data collection, all geared toward meeting the rigorous standards of each phase. Whether you are in the initial stages of drug development or conducting late-stage trials, Tekton is your reliable ally in navigating the complexities of the clinical research landscape. Trust us to deliver results that align with the highest standards of quality and integrity in the pursuit of advancing medicine and improving patient outcomes. #TektonResearch #TogetherTekton #ClinicalTrials #MakingLifeBetter
research and development is important.